Company

Sernova Corp

Headquarters: London, ON, Canada

CEO: Dr. Philip M. Toleikis

TSXV: SVA +0.87%

Market Cap

C$432.6 Million

CAD as of Aug. 1, 2022

US$335.8 Million

Market Cap History

Sernova Corp market capitalization over time

Evolution of Sernova Corp market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Sernova Corp

Detailed Description

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the long-term treatment of various serious chronic diseases, such as diabetes, hemophilia, and thyroid disease. Sernova Corp. has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected therapeutic cells; and a research agreement with the University of Miami to advance the development of Cell Pouch cell therapy platform. The company was incorporated in 1998 and is headquartered in London, Canada.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Sernova Corp has the following listings and related stock indices.


Stock: TSXV: SVA wb_incandescent

Stock: FSX: PSH wb_incandescent

Stock: OTC: SEOVF wb_incandescent

Stock: XETR: PSH wb_incandescent

Details

Headquarters:

The Stiller Centre

700 Collip Circle Suite 114

London, ON N6G 4X8

Canada

Fax: 519 858 5099